Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 15Thoracic 11Other hematologic neoplasm 9Breast 8Genitourinary 5Gastrointestinal 5Dermatologic 5CNS 5Plasma cell 4Gynecologic 4Sarcoma 3Classical hematology 3Myeloid 2Head & Neck 2Other solid neoplasm 1

Conditions

Malignant Solid Tumour 1

Interventions

pembrolizumab 26Cisplatin 15Pemetrexed 14Paclitaxel 14Carboplatin 14Nivolumab 10Cyclophosphamide 10Docetaxel 8atezolizumab 7Injections 7Melphalan 6tislelizumab 5olaparib 5Gemcitabine 5Filgrastim 5durvalumab 4aldesleukin 4Leucovorin 4Irinotecan 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Bevacizumab 4tocilizumab 3spartalizumab 3liposomal doxorubicin 3ixabepilone 3fludarabine 3epacadostat 3defactinib 3adavosertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vorinostat × Other solid neoplasm × Clear all
NCT00801151 2010-05-20

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Institut Claudius Regaud

Phase 1 Terminated
30 enrolled
Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡